ASCARI, EDOARDO
 Distribuzione geografica
Continente #
NA - Nord America 2.721
EU - Europa 2.253
AS - Asia 1.560
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
SA - Sud America 1
Totale 6.553
Nazione #
US - Stati Uniti d'America 2.705
CN - Cina 1.496
IE - Irlanda 682
UA - Ucraina 464
FI - Finlandia 313
SE - Svezia 267
DE - Germania 246
GB - Regno Unito 105
IT - Italia 85
FR - Francia 43
SG - Singapore 21
CA - Canada 16
IN - India 16
BE - Belgio 14
IR - Iran 14
NL - Olanda 12
AU - Australia 10
RU - Federazione Russa 9
DK - Danimarca 4
EU - Europa 4
HK - Hong Kong 3
RO - Romania 3
CZ - Repubblica Ceca 2
GR - Grecia 2
IQ - Iraq 2
JP - Giappone 2
MU - Mauritius 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BD - Bangladesh 1
ES - Italia 1
ID - Indonesia 1
JO - Giordania 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TR - Turchia 1
VN - Vietnam 1
Totale 6.553
Città #
Dublin 681
Chandler 591
Jacksonville 570
Nanjing 452
Nanchang 191
Ashburn 164
Princeton 137
Hebei 125
Lawrence 125
Shenyang 124
Beijing 123
Medford 121
Changsha 113
Wilmington 112
Jiaxing 99
Ann Arbor 77
Helsinki 76
Boardman 73
Hangzhou 70
Tianjin 70
Shanghai 38
Milan 35
Woodbridge 33
Norwalk 28
Verona 24
New York 20
Fairfield 19
Los Angeles 16
Seattle 15
Toronto 15
Brussels 14
Houston 12
Kunming 12
Jinan 10
Auburn Hills 9
Des Moines 9
Ningbo 8
Piscataway 8
San Genesio Ed Uniti 8
Singapore 8
Taizhou 7
Falls Church 6
Guangzhou 6
Orange 6
Zhengzhou 6
Andover 5
Ardabil 5
Chicago 5
Fuzhou 5
Melbourne 5
Lanzhou 4
San Francisco 4
Munich 3
Phoenix 3
Pune 3
Rockville 3
Sacramento 3
Tappahannock 3
Washington 3
Arlington 2
Borås 2
Brno 2
Changchun 2
Dearborn 2
Leawood 2
Naples 2
Pavia 2
Romainville 2
Rome 2
Tokyo 2
Adelaide 1
Amman 1
Amsterdam 1
Baghdad 1
Bari 1
Bridgeport 1
Canberra 1
Charlotte 1
Cupertino 1
Delhi 1
Desenzano Del Garda 1
Dhaka 1
Edmonton 1
Elphin 1
Groningen 1
Haikou 1
Hanoi 1
Hanover 1
Henderson 1
Inveruno 1
Karaganda 1
Kemerovo 1
Köln 1
Leidschendam 1
Maddingley 1
Newark 1
Novokuznetsk 1
Oslo 1
Pinehaven 1
Ponte Vedra Beach 1
Totale 4.572
Nome #
5' Nucleotidase in chronic B cell leukemias: a cytochemical and ultrastructural study 80
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 80
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 79
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 79
Anomalous erythrocytes produced by rabbits with liver damage. 78
A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12) 77
AMYLOIDOSIS AL 76
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 75
A prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma. 75
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 75
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 73
Acute phase proteins and prognosis in multiple myeloma. 72
Acute promyelocitic leukemia toluidine blue subtype. 70
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 69
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 69
Response to cyclosporin A and rhG-CSF in a case of aplastic anemia. 68
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 67
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 67
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 67
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 66
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 65
Reactive hemophagocytosis in Ki-1 positive largeb cell lymphoma: a case study. 65
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 64
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 64
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 63
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 63
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 63
Analysis of Vlambda-Jlambda expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambda III) as a new amyloid-associated germline gene segment 63
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 62
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 62
Anemie megaloblastiche. 62
Biologia e clinica del mieloma multiplo. 62
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 61
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 60
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 60
Glycopeptides of erythrocyte membranes in some hematological disorders 60
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 60
Changing clinical presentation of multiple myeloma. 60
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 60
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. 59
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 58
Possible evolution of human parvovirus B19 infection into erythroleukemia 58
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 58
Acquired immune thrombastenia: a new bleeding disorder. 58
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 58
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 58
Behaviour of young and old desialylated rabbit erythrocytes in vivo. 56
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 56
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 55
Applicazioni cliniche dei fattori di crescita emopoietici. 55
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 55
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 54
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 54
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis 54
Applicazioni cliniche della citometria. 53
Significance of marrow-blood barrier for CFU-GM in patients with acute nonlymphoid leukemia (AnLL) 53
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony stimulating factor. 52
Flow cytometric analysis of multidrug resistance antigen (p glicoprotein) and DNA ploidy in human colon cancer 52
Structural modifications in membrane glycoproteins during the erythrocyte life-span. 52
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high risk myelodysplastic syndromes 52
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 52
Membrane sialic acid and behaviour in vivo of rabbit "stress" macroreticulocytes. 51
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 50
Acute promyelocytic leukemia: morphological and clinical features. 50
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis 50
[Biochemical modifications of the erythrocyte membrane in various red cell disorders] 50
Acute non-lymphoblastic leukemia. Correlation between clinical and hematological parameters in 87 adult patients. 50
Terapia del mieloma multiplo. 49
Flow cytometric analysis of paraffin embedded material in human gastric cancer. 49
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. 49
[Pure acute monocytic leukaemia: morphological, cytochemical and clinical study of 14 cases (author's transl)]. 49
In vivo behaviour of neuraminidase-treated rabbit erythrocytes and reticulocytes 48
Cytokinetic studies on circulating neoplastic cells of Hodgkin's disease. 48
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 48
The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological study of a case. 48
New approaches to cancer chemotherapy. 47
Tetrahydrofolate dehydrogenase cytochemistry in acute lymphoblastic leukemia. 47
Fisiopatologia dell'eritrocito. 46
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 46
Chemotherapy-induced leukonychia 46
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma 45
Multilineage dysplasia without increased blasts identifies a poor prognosis subset of myelodysplastic syndromes. 45
Il trattamento del carcinoma mammario. 45
Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes 45
Erythrocyte membrane modifications in chronic granulocytic leukaemia 44
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. 44
[Glycoproteins of the erythrocyte membrane in normal and pathological conditions] 44
Post remission chemotherapy in adult non lymphoblastic leukemia: results of two protocols including intensive or non-intensive consolidation therapy. 44
Silymarine during maintenance therapy of acute promyelocytic leukemia. 43
IL MIELOMA MULTIPLO 43
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 43
[Prophylaxis and therapy of neuro-meningeal involvement of acute lymphoblastic leukemia. Case reports and critical review of literature (author's transl)] 43
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 43
Lymphocyte reactivity in chronic lymphocytic leukaemia: effect of repeated and prolonged stimulation with PHA and PWM. 43
Oral idarubicin and prednisone for advanced, previously untreated multiple myeloma: a pilot study. 42
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 42
Loss of the Y chromosome in smoldering acute leukemia. 42
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons] 42
Tecniche citochimiche e citocinetiche. 41
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 41
Totale 5.638
Categoria #
all - tutte 23.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.788


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.790 518 750 0 88 0 96 14 95 6 159 64 0
2020/2021875 92 71 32 84 7 129 3 134 32 137 117 37
2021/2022650 9 1 21 10 24 35 12 35 23 32 88 360
2022/20231.811 217 129 21 136 183 174 0 85 777 9 54 26
2023/2024550 80 92 25 59 51 133 15 32 7 14 25 17
2024/202526 26 0 0 0 0 0 0 0 0 0 0 0
Totale 6.627